SEC Form 4 · accession 0001437749-18-000258
CervoMed Inc. · CRVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David G Kalergis
Officer — Chairman and CEO · Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053691
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.18 | Jan 2, 2018 | A | 55,000 | A | — | Jan 2, 2028 | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F1The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2018.